After Teva's CEO resigned, BMO Capital has less confidence in the company's outlook. The firm states that the last time Teva went through the process of finding and installing a new CEO, its R&D and EPS reliability.declined slightly. The firm has been critical of the company's governance and keeps an Outperform rating on the stock. A previous version of the story incorrectly stated that the firm had kept a Market Perform rating on the shares.
- Investment & Company Information